(Q39547654)

13 September 2017

title

Humanized tumor mice--a new model to study and manipulate the immune response in advanced cancer therapy (English)

1 reference

13 September 2017

author

Arabel Vollmann-Zwerenz

5

object named as

Arabel Vollmann-Zwerenz

0 references

Gero Brockhoff

9

object named as

Gero Brockhoff

0 references

author name string

Anja K Wege

1

1 reference

13 September 2017

Wolfgang Ernst

2

1 reference

13 September 2017

Judith Eckl

3

1 reference

13 September 2017

Bernhard Frankenberger

4

1 reference

13 September 2017

Arabel Vollmann-Zwerenz

5

1 reference

13 September 2017

Daniela N Männel

6

1 reference

13 September 2017

Olaf Ortmann

7

1 reference

13 September 2017

Alexander Kroemer

8

1 reference

13 September 2017

Gero Brockhoff

9

1 reference

13 September 2017

language of work or name

English

0 references

publication date

21 July 2011

1 reference

International Journal of Cancer

13 September 2017

published in

1 reference

13 September 2017

volume

129

1 reference

13 September 2017

issue

9

1 reference

13 September 2017

page(s)

2194-2206

1 reference

Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor

13 September 2017

cites work

1 reference

NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy.

21 January 2018

1 reference

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

21 January 2018

1 reference

Of mice and not men: differences between mouse and human immunology

21 January 2018

1 reference

Monoclonal antibodies in clinical oncology

21 January 2018

1 reference

Monoclonal antibodies as therapeutic agents for cancer

21 January 2018

1 reference

The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma

21 January 2018

1 reference

Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma

21 January 2018

1 reference

Breast tumor cells isolated from in vitro resistance to trastuzumab remain sensitive to trastuzumab anti-tumor effects in vivo and to ADCC killing

21 January 2018

1 reference

Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo

21 January 2018

1 reference

Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model

21 January 2018

1 reference

Intrahepatically transplanted human cord blood cells reduce SW480 tumor growth in the presence of bispecific EpCAM/CD3 antibody

21 January 2018

1 reference

A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi-scid, IL-2Rγ(null) mouse lymphoma model

21 January 2018

1 reference

Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1

21 January 2018

1 reference

Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.

21 January 2018

1 reference

Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice

21 January 2018

1 reference

Humanized mice: are we there yet?

21 January 2018

1 reference

The innate NK cells, allograft rejection, and a key role for IL-15.

21 January 2018

1 reference

In vivo expansion of HLA-B35 alloreactive T cells sharing homologous T cell receptors: evidence for maintenance of an oligoclonally dominated allospecificity by persistent stimulation with an autologous MHC/peptide complex

21 January 2018

1 reference

Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence

21 January 2018

1 reference

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo

21 January 2018

1 reference

Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells

21 January 2018

1 reference

Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{ga

21 January 2018

1 reference

Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.

21 January 2018

1 reference

Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu

21 January 2018

1 reference

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance

21 January 2018

1 reference

In vivo assay of human NK-dependent ADCC using NOD/SCID/gammac(null) (NOG) mice

21 January 2018

1 reference

Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice.

21 January 2018

1 reference

IL-15 in the life and death of lymphocytes: immunotherapeutic implications

21 January 2018

1 reference

Natural killer cells: from bench to cancer therapy

21 January 2018

1 reference

Functional and phenotypic characterization of the humanized BLT mouse model

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26159

1 reference

release_sm4txq6jgrcttdsafgby4sqeqy

13 September 2017

Fatcat ID

0 references

1 reference